Lingxi Jiang

197 Ruijin 2Nd Road
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

RIVER delivers multimodal gene-directed regulatory interactions across diverse biological contexts with broad application potentials.

RIVER delivers multimodal gene-directed regulatory interactions across diverse biological contexts with broad application potentials.

Journal: Science China. Life sciences

Published: October 10, 2025

CEMIP2 sensitizes PDAC to chemotherapy through extracellular matrix remodeling by hyaluronan degradation.

CEMIP2 sensitizes PDAC to chemotherapy through extracellular matrix remodeling by hyaluronan degradation.

Journal: Cancer letters

Published: February 26, 2025

Nimotuzumab Plus Gemcitabine-based Adjuvant Chemotherapy for Resectable Pancreatic Cancer: A Retrospective Observational Study.

Nimotuzumab Plus Gemcitabine-based Adjuvant Chemotherapy for Resectable Pancreatic Cancer: A Retrospective Observational Study.

Journal: Pancreas

Published: February 24, 2025

Lipid Droplet-Organized MDM2-Mediated P53 Degradation: A Metabolic Switch Governing Diet-Driven Tumor Progression.

Lipid Droplet-Organized MDM2-Mediated P53 Degradation: A Metabolic Switch Governing Diet-Driven Tumor Progression.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 24, 2025

Molecular mechanisms and clinical value of the correlation between depression and cancer.

Molecular mechanisms and clinical value of the correlation between depression and cancer.

Journal: Medical oncology (Northwood, London, England)

Published: February 13, 2025

Accelerating IND-enabling toxicology studies using protein products from stable pools or pools of clones in Chinese hamster ovary cells.

Accelerating IND-enabling toxicology studies using protein products from stable pools or pools of clones in Chinese hamster ovary cells.

Journal: Biotechnology progress

Published: January 22, 2025

Identification of a Novel Small Molecule STING Agonist Reshaping the Immunomicroenvironment of Pancreatic Ductal Adenocarcinoma.

Identification of a Novel Small Molecule STING Agonist Reshaping the Immunomicroenvironment of Pancreatic Ductal Adenocarcinoma.

Journal: International journal of biological sciences

Published: November 28, 2024

TFAP2A enhances tumor stemness and promotes metastasis in pancreatic ductal adenocarcinoma.

TFAP2A enhances tumor stemness and promotes metastasis in pancreatic ductal adenocarcinoma.

Journal: iScience

Published: November 08, 2024

Driver mutation subtypes involve with differentiated immunophenotypes influencing pancreatic cancer outcomes.

Driver mutation subtypes involve with differentiated immunophenotypes influencing pancreatic cancer outcomes.

Journal: Cancer letters

Published: April 10, 2024

OFD1 inhibition induces BRCAness to create a therapeutic vulnerability to PARP inhibition in pancreatic cancer.

OFD1 inhibition induces BRCAness to create a therapeutic vulnerability to PARP inhibition in pancreatic cancer.

Journal: Nature communications

Published: April 01, 2024

Comprehensive analysis of KLF family reveals KLF6 as a promising prognostic and immune biomarker in pancreatic ductal adenocarcinoma.

Comprehensive analysis of KLF family reveals KLF6 as a promising prognostic and immune biomarker in pancreatic ductal adenocarcinoma.

Journal: Cancer cell international

Published: January 27, 2024

Combination therapy of KRAS G12V mRNA vaccine and pembrolizumab: clinical benefit in patients with advanced solid tumors.

Combination therapy of KRAS G12V mRNA vaccine and pembrolizumab: clinical benefit in patients with advanced solid tumors.

Journal: Cell research

Published: January 13, 2024

Showing 1-12 of 49

Last Updated: 09/26/2026